Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob Joseph

Showing results (171-180 of 192) with videos related to

Pageof 20
Sort By:
Journal of the American Medical Informatics Association : JAMIA|December 13, 2024
Effectiveness of electronic medical record-based strategies for death and hospital admission endpoint capture in pragmatic clinical trialsMaryam Rahafrooz, Danne C Elbers, Jay R Gopal, et al.
American Heart Journal|June 18, 2018
High-dose influenza vaccine to reduce clinical outcomes in high-risk cardiovascular patients: Rationale and design of the INVESTED trialOrly Vardeny, Jacob A Udell, Jacob Joseph, et al.
Scientific Reports|June 3, 2021
Association of the transthyretin variant V122I with polyneuropathy among individuals of African ancestryMargaret M Parker, Scott M Damrauer, Catherine Tcheandjieu, et al.
Journal of the American Medical Informatics Association : JAMIA|April 26, 2026
Increasing value in the Veterans Affairs Healthcare System (VA) with precision health: a continuing landmark collaboration with the Department of EnergyAmy C Justice, Benjamin McMahon, Daniel A Jacobson, et al.
Nature Communications|November 3, 2025
Genome-wide analysis of heart failure yields insights into disease heterogeneity and enables prognostic prediction in the Japanese populationNobuyuki Enzan, Kazuo Miyazawa, Satoshi Koyama, et al.
JAMA|December 4, 2020
Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical TrialOrly Vardeny, KyungMann Kim, Jacob A Udell, et al.
Nature Cardiovascular Research|February 6, 2025
Large-scale multi-omics identifies drug targets for heart failure with reduced and preserved ejection fractionDanielle Rasooly, Claudia Giambartolomei, Gina M Peloso, et al.
JAMA Internal Medicine|January 28, 2022
APOL1 Risk Variants, Acute Kidney Injury, and Death in Participants With African Ancestry Hospitalized With COVID-19 From the Million Veteran ProgramAdriana M Hung, Shailja C Shah, Alexander G Bick, et al.
Nature Genetics|April 8, 2025
Common-variant and rare-variant genetic architecture of heart failure across the allele-frequency spectrumDavid S M Lee, Kathleen M Cardone, David Y Zhang, et al.
Medrxiv : the Preprint Server for Health Sciences|July 28, 2023
Common- and rare-variant genetic architecture of heart failure across the allele frequency spectrumDavid S M Lee, Kathleen M Cardone, David Y Zhang, et al.
Pageof 20

Showing results (171-180 of 192) with videos related to

Sort By:
Pageof 20
Journal of the American Medical Informatics Association : JAMIA|December 13, 2024
Effectiveness of electronic medical record-based strategies for death and hospital admission endpoint capture in pragmatic clinical trialsMaryam Rahafrooz, Danne C Elbers, Jay R Gopal, et al.
American Heart Journal|June 18, 2018
High-dose influenza vaccine to reduce clinical outcomes in high-risk cardiovascular patients: Rationale and design of the INVESTED trialOrly Vardeny, Jacob A Udell, Jacob Joseph, et al.
Scientific Reports|June 3, 2021
Association of the transthyretin variant V122I with polyneuropathy among individuals of African ancestryMargaret M Parker, Scott M Damrauer, Catherine Tcheandjieu, et al.
Journal of the American Medical Informatics Association : JAMIA|April 26, 2026
Increasing value in the Veterans Affairs Healthcare System (VA) with precision health: a continuing landmark collaboration with the Department of EnergyAmy C Justice, Benjamin McMahon, Daniel A Jacobson, et al.
Nature Communications|November 3, 2025
Genome-wide analysis of heart failure yields insights into disease heterogeneity and enables prognostic prediction in the Japanese populationNobuyuki Enzan, Kazuo Miyazawa, Satoshi Koyama, et al.
JAMA|December 4, 2020
Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical TrialOrly Vardeny, KyungMann Kim, Jacob A Udell, et al.
Nature Cardiovascular Research|February 6, 2025
Large-scale multi-omics identifies drug targets for heart failure with reduced and preserved ejection fractionDanielle Rasooly, Claudia Giambartolomei, Gina M Peloso, et al.
JAMA Internal Medicine|January 28, 2022
APOL1 Risk Variants, Acute Kidney Injury, and Death in Participants With African Ancestry Hospitalized With COVID-19 From the Million Veteran ProgramAdriana M Hung, Shailja C Shah, Alexander G Bick, et al.
Nature Genetics|April 8, 2025
Common-variant and rare-variant genetic architecture of heart failure across the allele-frequency spectrumDavid S M Lee, Kathleen M Cardone, David Y Zhang, et al.
Medrxiv : the Preprint Server for Health Sciences|July 28, 2023
Common- and rare-variant genetic architecture of heart failure across the allele frequency spectrumDavid S M Lee, Kathleen M Cardone, David Y Zhang, et al.
Pageof 20